GGrantIndex
Sort

17,054 grants matching genome editing

Mapping Drug Resistance Genes in Plasmodium falciparum

$923,047
Tim J Anderson · Texas Biomedical Research Institute · R37 · FY2021 · AI

Optimizing Strategies to Overcome Kidney Xenograft Rejection

$922,996
Andrew B Adams · Emory University · R01 · FY2019 · AI

Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems

$922,843
Jay Ashok Shendure · University Of Washington · UM1 · FY2021 · HG

Novel Gene Editing Approaches for Hemoglobinopathies

$921,786
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2019 · HL

Novel Gene Editing Approaches for Hemoglobinopathies

$921,786
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2020 · HL

Collaborative Research: ORCC: Harnessing Adaptive Variation in Drought Resistance Strategies to Manage Populations Under Climate Change

$921,095
Benjamin K Blackman · University Of California-Berkeley · · FY2022 · BIO

Lymphoma Disease Discovery and Definition

$920,437
Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Neuronal Intracellular Signaling Underlying Synaptic, Circuit and Behavioral Plasticity

$919,251
Ryohei Yasuda · Max Planck Florida Corporation · R35 · FY2020 · NS

Environmental Epigenomics and Precision Environmental Health

$918,277
Dana Dolinoy · University Of Michigan At Ann Arbor · R35 · FY2021 · ES

Foundational Mapping of the Neural Circuits that Control Intrinsic Lung Function

$918,200
Xin Sun · University Of California, San Diego · OT2 · FY2019 · OD

Clinical Cancer Genomics Program

$917,710
Kathleen Calzone · Division Of Basic Sciences - Nci · ZID · FY2021 · CA

Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides

$917,358
Paul B McCray · University Of Iowa · UH3 · FY2021 · HL

Therapeutic Targeting of Malignant Glioma Stem Cells

$916,993
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2021 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$916,993
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2020 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$916,993
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2017 · CA

Chemical Proteomic Platforms for Radically Expanding Cancer Druggability

$916,320
Benjamin F Cravatt · Scripps Research Institute, The · R35 · FY2025 · CA

Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication

$915,398
Binhua Ling · Texas Biomedical Research Institute · R01 · FY2022 · MH

Gene Expression for Functional Genomics in Human Populations

$915,265
Christopher O'Donnell · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Lentivirus-like particle specific delivery of Cas12 ribonucleoprotein (RNP) to HIV reservoir cells in vivo for an HIV cure

$915,099
Wenhui Hu · Temple Univ Of The Commonwealth · R01 · FY2023 · AI

Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians

$914,965
Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Next generation hybrid nucleases for precise excision of latent HIV-1 provirus

$914,295
Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI

Next generation hybrid nucleases for precise excision of latent HIV-1 provirus

$914,295
Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AI

Collaborative Expansion of Marmoset Colonies for Neuroscience Research

$913,417
Jon E Levine · University Of Wisconsin-Madison · U24 · FY2023 · MH

Vector Biological Studies in Leishmaniasis

$911,807
David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Posttranscriptional regulation by mRNA-binding shuttling and transport proteins

$910,617
Thomas Tuschl · Rockefeller University · R01 · FY2012 · GM